22nd Century Group

FDA’s Plan to Lower Nicotine in Cigarettes to Non-Addictive Levels Shines Spotlight on 22nd Century Group

CLARENCE, N.Y. July 31, 2017 (STL.NEWS)  22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is focused on tobacco harm reduction, stated today that the Company welcomes the announcement by the United States Food and Drug Administration (FDA) that the Agency is exercising its authority under the Family Smoking Prevention and Tobacco Control … Continue reading FDA’s Plan to Lower Nicotine in Cigarettes to Non-Addictive Levels Shines Spotlight on 22nd Century Group